跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,633 条关于
“STAT3 Inhibitor”
全部
21,633
临床试验
11,117
药物
4,152
机构
145
资讯
6,219
9个月前
STAT3 Inhibitor Safety Concerns Highlight Alternative Approaches in IPF Drug Development
去年
Tvardi Therapeutics Completes Merger with Cara, Advances STAT3 Inhibitor Programs for Fibrosis-Driven Diseases
3年前
Tvardi Therapeutics to Present Phase 1 Trial Data of STAT3 Inhibitor TTI-101 at ASCO 2023
去年
First-in-Class STAT3 Inhibitor Shows Promise in Feline Cancer Trial with Human Applications
上个月
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for STAT3 Inhibitor TTI-109, Plans 2027 Trial
去年
First-in-Class STAT3 Inhibitor Shows Promise in Feline Head and Neck Cancer Trial with Human Applications
2年前
Moleculin Biotech's STAT3 Inhibitor WP1066 Enters Phase 2 Trial for Glioblastoma
去年
TTI-101 Shows Promise in Advanced Cancer Treatment by Targeting STAT3
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
10个月前
STAT Inhibitor Pipeline Expands with 22 Drugs Across 18 Companies Targeting Cancer and Inflammatory Diseases
第 1 页,共 622 页
上一页
下一页